Key Market Indicators
Sales of antihypertensive medicines in Luxembourg are expected to reach $400,000 by 2026, down 1.9% annually from the 2021 figure of $440,000. Since 2000, demand has decreased by 2.5% every year. In 2021, Luxembourg was in 26th place, overtaken by Iceland with $440,000. Italy, Spain and Australia were ranked 2nd, 3rd and 4th respectively.
